Inhibitory Effect of Vitamin E Succinate Combined with Adriamycin on the Growth of Human Breast Cancer Cell Line Bcap-37

张伟,张军初,朱大乔,徐昕昀,张玲珍,王强

DOI: https://doi.org/10.3969/j.issn.1001-5930.2005.03.003

2005-01-01

Abstract:Objective To investigate the inhibitory effect of vitamin E succinate(VES) combined with adriamycin(ADM) on the growth of human breast cancer cell line Bcap-37.Methods Bcap-37 human breast cancer cells were treated with VES(5 mg/L,10 mg/L and 20 mg/L) and ADM(0.25 mg/L,1 mg/L and 2 mg/L) for 24 h and 36 h.The inhibitory effect on the growth was measured with MTT method.Cell cycle and cell surface Fas expression were analyzed with flow cytometry.Results The combination of VES with ADM had significant inhibitory effect on the growth of Bcap-37 human breast cancer cells.Flow cytometry showed the apoptotic rate of Bcap-37 was 0.7%.Apoptotic rates of cells,when treated with VES at the concentration of 5 mg/L and 20 mg/L and ADM at 1 mg/L and 2 mg/L,were 10.1% and 19.2%,16.0% and 23.3% respectively,and increased to 31.1% and 40.7% when treated with 5 mg/L VES combine with 1 mg/L ADM and 20 mg/L VES combine with 2 mg/L,respectively.Cell surface Fas expression increased after being treated with VES combined with ADM.Conclusion VES combined with ADM had significant inhibitory effect on the growth of Bcap-37 human breast cancer cells.The mechanism may relate to the upregulated expression of Fas on the surface of cancer cells.